Feb. 09, 2023

Australian patent granted for theranostic assay platform

Feb. 02, 2023

Kick-off day for new EU Project FORCE REPAIR: Innovating Chronic Wound Treatment

As a member of a multi-disciplinary and multi-national consortium, Akribes was granted funding by the European Union for the Horizon Europe project entitled FORCE REPAIR, the acronym for “smart and multiFunctional 3D printable prO-Regenerative biologiCal matrix modulating mEchanotRansduction as advancEd theraPy to treAt skIn chRonic wounds.”
The goal of this ambitious project is to improve chronic wound treatment with customized wound dressings by 3D-printing of functionalized bio-inks to relieve skin tension, fight infection, reduce inflammation and support regeneration of healthy tissue.

Please see the FORCE_REPAIR_Press release for more details, and follow the project on the website https://forecepair-wounds.eu and the FORCE REPAIR LinkedIn account.

 Project funded by the European Union

Sept. 13, 2022

Japanese patent granted for theranostic assay platform

Aug. 02, 2022

Chinese patent granted for theranostic assay platform

Mar. 28, 2022

TÜV Süd granted an ISO 13485:2016 Certificate for the Akribes Quality Management System (QMS)

The QMS at Akribes complies with the DIN EN ISO13485:2016 standard for medical devices. The certificate covers the scope of “Design and Development, Production and Sales of lab-on-a-chip devices and IVD software for diagnostics and therapy recommendation for chronic/non-healing wounds.

June 02, 2021

EU patent granted for selected drugs

Mar. 03, 2021

EU patent granted for drug combinations

Oct. 03, 2019

EU patent granted for theranostic assay platform